Pascale Boissel
Vermogen: 1 852 $ op 30-06-2026
Vermogen: 1 852 $ op 30-06-2026
Ms. Pascale Boissel is an Independent Member-Supervisory Board at Innate Pharma SA and an Independent Non-Executive Director at Sartorius Stedim Biotech SA. She is on the Board of Directors at Innate Pharma SA and Sartorius Stedim Biotech SA. Ms. Boissel was previously employed as a CFO, Director-Finance & Administration by ENYO Pharma SA, a Chief Financial Officer by Novadiscovery SA, an Independent Director by Poxel SA, a Director-Finance & Administration & Deputy CEO by BioAster, and a Chief Financial Officer & Head-Media Relations by Ipsogen SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from École des Hautes Études Commerciales de Paris.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-03-2026 | 1.000 ( 0% ) | 1 852 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Directeur/Bestuurslid | 26-03-2019 |
| INNATE PHARMA | Directeur/Bestuurslid | 19-05-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Financieel Directeur/CFO | 01-01-2021 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Financieel Directeur/CFO | 01-05-2018 |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Financieel Directeur/CFO | 01-12-2016 |
| QIAGEN MARSEILLE | Financieel Directeur/CFO | 01-01-2012 |
| POXEL | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic tests for cancer | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau